A Study of ZW191 in Participants With Solid Tumors (NCT06555744)

🧪 Interventions in This Study

• ZW191 (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (27 Sites)

Showing the first 25 of 27 sites.

• Yale University — New Haven, Connecticut
• The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute — Columbus, Ohio
• Stephenson Cancer Center — Oklahoma City, Oklahoma
• NEXT Oncology — San Antonio, Texas
• NEXT Virginia — Fairfax, Virginia
• Linear Clinical Research — Nedlands,
• Royal North Shore Hospital Northern Sydney Cancer Centre — St Leonards,
• National Cancer Center Hospital East — Kashiwa-shi,
• Saitama Medical University International Medical Center — Saitama,
• National Cancer Center Hospital — Tokyo,
• The Cancer Institute Hospital of JFCR — Tokyo,
• National University Health System (NUHS) - National University Cancer Institute Singapore (NCIS) — Singapore,
• National Cancer Centre Singapore — Singapore,
• Curie Oncology — Singapore,
• National Cancer Center — Goyang-si,
• Seoul National University Bundang Hospital — Seongnam-si,
• Seoul National University Hospital — Seoul,
• Severance Hospital, Yonsei University Health System — Seoul,
• Asan Medical Center — Seoul,
• Samsung Medical Center — Seoul,
• Gangnam Severance Hospital — Seoul,
• Hospital Universitari Vall d'Hebron — Barcelona,
• Hospital Universitario Reina Sofia — Córdoba,
• Clínica Universidad de Navarra — Madrid,
• NEXT Oncology Madrid — Madrid,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Advanced Solid Tumors

• A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma — Scottsdale, Arizona
• A Study of MRG002 in Patients with HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer — Orange, California
• QTX3544 in Patients With Advanced Solid Tumors With KRAS G12V Mutations — Denver, Colorado
• A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors — Denver, Colorado
• A Phase 1 Dose-escalation Study of FF-10832 for Treatment of Solid Tumors Including Biliary Tract Cancer — Scottsdale, Arizona
• A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations — Los Angeles, California

Explore by condition: All Advanced Solid Tumors clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.